Search research articles
Contact Us
Filters
Showing results (1-10 of 253) with videos related to
Page
of 26
Sort By:
International Journal of Cardiology
|
September 21, 2015
Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis
Simona Silvetti, Markku S Nieminen
The American Journal of Cardiology
|
September 27, 2005
Definition and epidemiology of acute heart failure syndromes
Markku S Nieminen, Veli-Pekka Harjola
European Journal of Heart Failure
|
March 12, 2008
Heart failure in the elderly: how risky is it to be discharged?
Markku S Nieminen, Veli-Pekka Harjola
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|
November 26, 2003
Considerations on the efficacy and safety of levosimendan in ischemic heart failure
Markku S Nieminen, Esa-Pekka Sandell
Annals of Medicine
|
March 10, 2020
Poor adherence to beta-blockers is associated with increased long-term mortality even beyond the first year after an acute coronary syndrome event
Jaakko Allonen, Markku S Nieminen, Juha Sinisalo
International Journal of Cardiology
|
July 27, 2013
Lessons from Lisbon on AHF drug treatment: is it really true that all-old-failed-all-new-will-succeed?
Piero Pollesello, Zoltán Papp, Markku S Nieminen
European Journal of Epidemiology
|
September 17, 2003
Clinical findings, outcome and treatment in patients > or = 75 years with acute myocardial infarction
Mervi Kotamäki, Timo E Strandberg, Markku S Nieminen
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
December 19, 2017
The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
Markku S Nieminen, Cândida Fonseca, Dulce Brito, et al.
Journal of Cardiovascular Pharmacology
|
March 12, 2009
Effects of levosimendan on the energy balance: preclinical and clinical evidence
Markku S Nieminen, Piero Pollesello, Gusztáv Vajda, et al.
Scandinavian Cardiovascular Journal : SCJ
|
May 25, 2002
Stimulated release of endothelin-converting enzyme is simultaneous with tissue-type plasminogen activator and decrease in coronary heart disease
Juha Sinisalo, Frej Fyhrquist, Martti Syrjälä, et al.
Page
of 26
Search research articles
Search
Showing results (1-10 of 253) with videos related to
Sort By:
Page
of 26
International Journal of Cardiology
|
September 21, 2015
Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis
Simona Silvetti, Markku S Nieminen
The American Journal of Cardiology
|
September 27, 2005
Definition and epidemiology of acute heart failure syndromes
Markku S Nieminen, Veli-Pekka Harjola
European Journal of Heart Failure
|
March 12, 2008
Heart failure in the elderly: how risky is it to be discharged?
Markku S Nieminen, Veli-Pekka Harjola
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|
November 26, 2003
Considerations on the efficacy and safety of levosimendan in ischemic heart failure
Markku S Nieminen, Esa-Pekka Sandell
Annals of Medicine
|
March 10, 2020
Poor adherence to beta-blockers is associated with increased long-term mortality even beyond the first year after an acute coronary syndrome event
Jaakko Allonen, Markku S Nieminen, Juha Sinisalo
International Journal of Cardiology
|
July 27, 2013
Lessons from Lisbon on AHF drug treatment: is it really true that all-old-failed-all-new-will-succeed?
Piero Pollesello, Zoltán Papp, Markku S Nieminen
European Journal of Epidemiology
|
September 17, 2003
Clinical findings, outcome and treatment in patients > or = 75 years with acute myocardial infarction
Mervi Kotamäki, Timo E Strandberg, Markku S Nieminen
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
December 19, 2017
The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
Markku S Nieminen, Cândida Fonseca, Dulce Brito, et al.
Journal of Cardiovascular Pharmacology
|
March 12, 2009
Effects of levosimendan on the energy balance: preclinical and clinical evidence
Markku S Nieminen, Piero Pollesello, Gusztáv Vajda, et al.
Scandinavian Cardiovascular Journal : SCJ
|
May 25, 2002
Stimulated release of endothelin-converting enzyme is simultaneous with tissue-type plasminogen activator and decrease in coronary heart disease
Juha Sinisalo, Frej Fyhrquist, Martti Syrjälä, et al.
Page
of 26